February 2024: Servier announced FDA acceptance and priority review of the NDA for vorasidenib, which could become the first ...

The dynamics of the CAR-T cell therapy market for multiple myeloma are anticipated to change due to extensive R&D activities, increased investment in research and development of new CAR-T cell ...

The AHR agonist market is experiencing growth, driven by the rising awareness of AHR's involvement in immune regulation, skin ...

The diffuse cutaneous systemic sclerosis market landscape is evolving from conventional symptom-focused strategies toward therapies that specifically target fibrosis and immune modulation, addressing ...

Europa Universalis 5 armies are integral to any campaign, so Paradox explains how your pops, food supplies, and levies will work in EU5.

DelveInsight's CXCR Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

DelveInsight's HPV+ Oropharyngeal Cancer Market Insights report includes a comprehensive understanding of current treatment practices, HPV+ oropharyngeal cancer emerging drugs, market share of ...

The platinum-resistant ovarian cancer market is expanding due to a growing unmet need, as many patients relapse after first-line platinum therapies, driving demand for novel second- ...

The hereditary transthyretin amyloidosis market is experiencing significant growth driven by increasing disease awareness, advancements in gene-silencing therapies, and the rising ...